The landscape of dementia diagnosis has advanced drastically with the appearance of advanced biomarkers, which include amyloid PET scans, tau imaging, and blood-centered tests that will detect Alzheimer's pathology several years in advance of symptoms emerge. Whilst these technological developments symbolize impressive development in knowledge neur